Edwin P. Alyea

Duke University — United States

Medicine · Health Sciences

91h-index26.3kcitations551works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(307), Acute Myeloid Leukemia Research(120), Chronic Lymphocytic Leukemia Research(89), T-cell and B-cell Immunology(87), Immune Cell Function and Interaction(80)

Publications549 total

CT-866: Impact of Sociodemographic Factors on Conditioning Intensity and Outcomes of Hematopoietic Cell Transplant Recipients With Myeloid Malignancies
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: CT-866 Impact of Sociodemographic Factors on Conditioning Intensity and Outcomes of Hematopoietic Cell Transplant Recipients With Myeloid Malignancies
Clinical Lymphoma Myeloma & Leukemia·2025
A retrospective study on beta-blocker use and outcomes in hematopoietic stem cell transplant patients
PeerJ·2025Open Access
Food insecurity prior to hematopoietic stem cell transplant is associated with malnutrition and worse outcomes
Bone Marrow Transplantation·2025
Barriers to Autologous Stem Cell Transplant Referral in Multiple Myeloma: Impact of Social Determinants on Referral, Evaluation, and Transplant Outcomes
Transplantation and Cellular Therapy·2025
Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation
JAMA Oncology·2025· 7 citedOpen Access
Disparities in CAR-T Therapy Access and Outcomes: Variation in Referral Patterns for CAR-T Therapy in Patients with Newly Diagnosed Malignancies at an Academic Center in North Carolina
Blood·2024· 1 citedOpen Access
Understanding Sociodemographic Barriers in Hematopoietic Stem Cell Transplantation Among Patients with Hematologic Malignancies: Insights from a North Carolina Cohort
Blood·2024Open Access
Timing of allogeneic hematopoietic cell transplantation for myelofibrosis and other myeloproliferative neoplasms.
Journal of Clinical Oncology·2024
Acceptance and Commitment Therapy May Improve Physical Function after Allogeneic Hematopoietic Stem Cell Transplant
Transplantation and Cellular Therapy·2024· 1 cited
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
Cell Reports·2023· 1 citedOpen Access
Supplementary Data from Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion
2023Open Access
Supplemental Table 1 from Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
2023Open Access
Data from Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
2023Open Access
Data from Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
2023Open Access
Supplemental Table 1 legend from Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
2023Open Access
Data from Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
2023Open Access
Supplementary Data from Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report
2023Open Access
Data from Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion
2023Open Access
Supplemental Table 1 legend from Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
2023Open Access
page 1 of 28Next →

Frequent Co-authors

Robert J. Soiffer(45), Joseph H. Antin(35), Vincent T. Ho(31), Corey Cutler(29), Jerome Ritz(26), Haesook T. Kim(23), John Koreth(20), Philippe Armand(16), Stephanie J. Lee(13), Donna Neuberg(8), Yi‐Bin Chen(6), Richard M. Stone(6), Richard T. Maziarz(5), Mary M. Horowitz(5), Steven M. Devine(5), Robert Schlossman(5), John G. Gribben(5), Karen K. Ballen(5), Ken‐ichi Matsuoka(4), Sean M. McDonough(4)